Docosahexaenoic Acid Enhances Oxaliplatin-Induced Autophagic Cell Death via the ER Stress/Sesn2 Pathway in Colorectal Cancer

Oxaliplatin is an anticancer drug administered to colorectal cancer (CRC) patients in combination with 5-fluorouracil and antibodies (bevacizumab and cetuximab), thereby significantly improving the survival rate of CRC. However, due to various side effects associated with the above treatment strateg...

Descripción completa

Detalles Bibliográficos
Autores principales: Jeong, Soyeon, Kim, Dae Yeong, Kang, Sang Hee, Yun, Hye Kyeong, Kim, Jung Lim, Kim, Bo Ram, Park, Seong Hye, Na, Yoo Jin, Jo, Min Jee, Jeong, Yoon A., Kim, Bu Gyeom, Lee, Dae-Hee, Oh, Sang Cheul
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2019
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6678695/
https://www.ncbi.nlm.nih.gov/pubmed/31337142
http://dx.doi.org/10.3390/cancers11070982

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6678695/
https://www.ncbi.nlm.nih.gov/pubmed/31337142
http://dx.doi.org/10.3390/cancers11070982

Ejemplares similares